Joyce is also set to leave GMO. Also, American Century's LIVESTRONG funds withstand Lance Armstrong controversy, Dreyfus' CEO departs, manager changes at Fidelity and American Century, and analyst reductions at UBS Global Asset Management.
Plus, two Vanguard heavyweights disagree on proposed securities transaction tax.
Plus, news on Matthews, value managers buying Dell, Oppenheimer, American Funds, Fidelity, and more.
Plus, changes at Fidelity, Pax World, Osterweis, and more.
Plus, Vanguard Bond ETFs, First Trust pulls the old switcharoo, and more.